AU2002227112A1 - Affinity maturation by competitive selection - Google Patents

Affinity maturation by competitive selection

Info

Publication number
AU2002227112A1
AU2002227112A1 AU2002227112A AU2711202A AU2002227112A1 AU 2002227112 A1 AU2002227112 A1 AU 2002227112A1 AU 2002227112 A AU2002227112 A AU 2002227112A AU 2711202 A AU2711202 A AU 2711202A AU 2002227112 A1 AU2002227112 A1 AU 2002227112A1
Authority
AU
Australia
Prior art keywords
fragment
competitor
binding
binding pair
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227112A
Other languages
English (en)
Inventor
Robert F. Balint
Jeng-Horng Her
James W. Larrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humanigen Inc
Original Assignee
Horizon Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Biotechnologies Inc filed Critical Horizon Biotechnologies Inc
Publication of AU2002227112A1 publication Critical patent/AU2002227112A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AU2002227112A 2000-10-30 2001-10-30 Affinity maturation by competitive selection Abandoned AU2002227112A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24503900P 2000-10-30 2000-10-30
US60/245,039 2000-10-30
PCT/US2001/045371 WO2002036738A2 (en) 2000-10-30 2001-10-30 Affinity maturation by competitive selection

Publications (1)

Publication Number Publication Date
AU2002227112A1 true AU2002227112A1 (en) 2002-05-15

Family

ID=22925059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002227112A Abandoned AU2002227112A1 (en) 2000-10-30 2001-10-30 Affinity maturation by competitive selection

Country Status (6)

Country Link
US (1) US20020155502A1 (de)
EP (1) EP1330551A2 (de)
JP (1) JP2004521616A (de)
AU (1) AU2002227112A1 (de)
CA (1) CA2427747A1 (de)
WO (1) WO2002036738A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148110B2 (en) * 1999-03-15 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Detection of molecular interactions by β-lactamase reporter fragment complementation
ATE552348T1 (de) 2000-10-19 2012-04-15 Target Discovery Inc Massendefektetikettierung zur bestimmung von oligomersequenzen
US7432063B2 (en) * 2002-02-14 2008-10-07 Kalobios Pharmaceuticals, Inc. Methods for affinity maturation
US7335478B2 (en) * 2002-04-18 2008-02-26 Kalobios Pharmaceuticals, Inc. Reactivation-based molecular interaction sensors
WO2004072266A2 (en) * 2003-02-13 2004-08-26 Kalobios Inc. Antibody affinity engineering by serial epitope-guided complementarity replacement
ATE411384T1 (de) * 2005-05-04 2008-10-15 Signalomics Gmbh Kompetitives n-hybrid system
IN2014DN06624A (de) 2005-10-18 2015-07-10 Univ Colorado
BRPI0713206A2 (pt) * 2006-06-30 2012-04-17 Applera Corp métodos de análise das interações das ligações
AU2009246876B2 (en) 2008-05-16 2015-04-02 Taiga Biotechnologies, Inc. Antibodies and processes for preparing the same
DK2966084T3 (en) 2008-08-28 2018-08-06 Taiga Biotechnologies Inc MODULATORS OF MYC, PROCEDURES FOR USING SAME AND PROCEDURES FOR IDENTIFYING SUBSTANCES MODULATING MYC
SG11201500429QA (en) 2012-07-20 2015-03-30 Taiga Biotechnologies Inc Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
KR20190092472A (ko) 2016-12-02 2019-08-07 타이가 바이오테크놀로지스, 인코포레이티드 나노입자 제제
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594120A (en) * 1994-02-18 1997-01-14 Brigham And Women's Hospital, Inc. Integrin alpha subunit
US5925523A (en) * 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
AU7269098A (en) * 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6110695A (en) * 1997-12-02 2000-08-29 The Regents Of The University Of California Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
JP2003500051A (ja) * 1999-05-25 2003-01-07 パノラマ リサーチ，インコーポレイティド 相互作用活性化タンパク質
US7544477B2 (en) * 2000-01-13 2009-06-09 Kalobios, Inc. Circularly permutated, interaction-activated proteins
US7252952B2 (en) * 2000-03-06 2007-08-07 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein—protein interaction
AU2001261499A1 (en) * 2000-05-12 2001-11-26 Yale University Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins

Also Published As

Publication number Publication date
WO2002036738A3 (en) 2002-07-04
EP1330551A2 (de) 2003-07-30
WO2002036738A2 (en) 2002-05-10
US20020155502A1 (en) 2002-10-24
JP2004521616A (ja) 2004-07-22
CA2427747A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
US7432063B2 (en) Methods for affinity maturation
US10041063B2 (en) Polypeptide display libraries and methods of making and using thereof
Binder et al. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface
EP2882844B1 (de) Protease-resistente systeme für polypeptiddisplay sowie verfahren zu ihrer herstellung und verwendung
US20020155502A1 (en) Affinity maturation by competitive selection
US7335478B2 (en) Reactivation-based molecular interaction sensors
US20060094062A1 (en) Ultra high throughput capture lift screening methods
US20030157579A1 (en) Molecular sensors activated by disinhibition
CN105247050B (zh) 用于文库构建、亲和力结合剂筛选和其表达的整合系统
US7544477B2 (en) Circularly permutated, interaction-activated proteins
EP1183347A1 (de) Durch wechselwirkung aktivierte proteine
US20020106783A1 (en) Bacterial multi-hybrid system and applications
EP1536005A1 (de) Verfahren zum testen der wechselwirkung zwischen proteinen
EP2358909B1 (de) System zur protokollierung von wechselwirkungen zwischen proteinen im bakteriellen periplasma
US10093920B2 (en) Protein display
US20040038317A1 (en) Breakpoint fusion fragment complementation system
WO2003068945A2 (en) Detection of molecular interaction by reactivation of an auto-inhibited responder (rair)
WO2023227893A1 (en) Split reporter complex for protein-complementation assays
WO2009102080A1 (en) Vector for screening antibody
Rice Development and optimization of bacterial display methodologies for peptide library screening